Batzloff MR - Search Results

1

The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates Against Group A Streptococcus.

Ghaffar KA, Marasini N, Giddam AK, Batzloff MR, Good MF, Skwarczynski M, Toth I. Ghaffar KA, et al. Among authors: batzloff mr. Med Chem. 2016;13(1):22-27. doi: 10.2174/1573406412666160720093138. Med Chem. 2016. PMID: 27449794

2

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

Brandt ER, Sriprakash KS, Hobb RI, Hayman WA, Zeng W, Batzloff MR, Jackson DC, Good MF. Brandt ER, et al. Among authors: batzloff mr. Nat Med. 2000 Apr;6(4):455-9. doi: 10.1038/74719. Nat Med. 2000. PMID: 10742155

3

Adapting immunity with subunit vaccines: case studies with group A Streptococcus and malaria.

Good MF, Xu H, Batzloff M. Good MF, et al. Int J Parasitol. 2002 May;32(5):575-80. doi: 10.1016/s0020-7519(01)00360-5. Int J Parasitol. 2002. PMID: 11943230 Review.

4

A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.

Olive C, Batzloff MR, Horváth A, Wong A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: batzloff mr. Infect Immun. 2002 May;70(5):2734-8. doi: 10.1128/IAI.70.5.2734-2738.2002. Infect Immun. 2002. PMID: 11953422 Free PMC article.

5

Parenteral and mucosal delivery of a novel multi-epitope M protein-based group A streptococcal vaccine construct: investigation of immunogenicity in mice.

Dunn LA, McMillan DJ, Batzloff M, Zeng W, Jackson DC, Upcroft JA, Upcroft P, Olive C. Dunn LA, et al. Vaccine. 2002 Jun 21;20(21-22):2635-40. doi: 10.1016/s0264-410x(02)00206-2. Vaccine. 2002. PMID: 12034087

6

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Infect Immun. 2003 May;71(5):2373-83. doi: 10.1128/IAI.71.5.2373-2383.2003. Infect Immun. 2003. PMID: 12704107 Free PMC article.

7

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection.

Batzloff MR, Hayman WA, Davies MR, Zeng M, Pruksakorn S, Brandt ER, Good MF. Batzloff MR, et al. J Infect Dis. 2003 May 15;187(10):1598-608. doi: 10.1086/374800. Epub 2003 Apr 30. J Infect Dis. 2003. PMID: 12721940

8

Vaccine development for group A streptococcus infections and associated disease.

Batzloff MR, Sriprakash KS, Good MF. Batzloff MR, et al. Curr Drug Targets. 2004 Jan;5(1):57-69. doi: 10.2174/1389450043490721. Curr Drug Targets. 2004. PMID: 14738218 Review.

9

Lipid core peptide technology and group A streptococcal vaccine delivery.

Olive C, Batzloff MR, Toth I. Olive C, et al. Among authors: batzloff mr. Expert Rev Vaccines. 2004 Feb;3(1):43-58. doi: 10.1586/14760584.3.1.43. Expert Rev Vaccines. 2004. PMID: 14761243 Free article. Review.

10

Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Indian J Med Res. 2004 May;119 Suppl:88-94. Indian J Med Res. 2004. PMID: 15232170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters